Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 211 posts found.

lilly_scientists

Lilly increases Alzheimer’s R&D

April 18, 2013
Research and Development, Sales and Marketing Alzheimer's, lilly

Eli Lilly and Company has bought a new diagnostic technology which may help point to a different way of treating …

News
lilly_corporate_hq

Lilly Phase III diabetes boost

April 17, 2013
Research and Development, Sales and Marketing diabetes, dulaglutide, lilly

Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …

News
FDA image

FDA offers Alzheimer’s guidance

February 11, 2013
Research and Development, Sales and Marketing Alzheimer's, FDA, Roche, lilly

The FDA has issued guidance to help companies developing new treatments for patients with early-stage Alzheimer’s disease. The US regulator’s …

News

Pharma manufacturing news in brief

February 11, 2013
Manufacturing and Production Almac, MeadWestvaco, Rexam, UPS, lilly

A round-up of pharma manufacturing news, including facility updates from MeadWestvaco, Rexam, Almac, UPS and Kemwell Biopharma. MeadWestvaco has said …

News
lilly image

Lilly abandons RA drug

February 8, 2013
Research and Development, Sales and Marketing RA, lilly, tabalumab

Lilly is abandoning its late-stage trial into investigational rheumatoid arthritis (RA) drug tabalumab but insists the move has nothing to …

News
lilly image

Survey shock for pharma

February 4, 2013
Medical Communications, Research and Development, Sales and Marketing Cancer, PACE, lilly, pharma, research

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …

News

Lilly hit by Zyprexa losses

January 30, 2013
Sales and Marketing antipsychotic, lilly, zyprexa

The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …

News
Lilly image

EU nod for Lilly brain diagnostic

January 18, 2013
Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly

Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …

News
Tamoxifen image

NICE consults on tamoxifen

January 15, 2013
Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen

Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …

News

Boehringer hands back Lilly drug

January 8, 2013
Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly

Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …

News
Evonik image

Evonik swings axe at API plant

December 18, 2012
Manufacturing and Production API, Evonik, cuts, lilly

Fine chemicals company Evonik Degussa has announced job cuts as part of an efficiency drive at a US plant making …

News
Astrazeneca image

RA setbacks for AstraZeneca and Lilly

December 14, 2012
Research and Development, Sales and Marketing AstraZeneca, Humira, RA, lilly

AstraZeneca and Eli Lilly have both suffered setbacks in their attempts to push their respective investigational rheumatoid arthritis (RA) treatments …

News
dr_jean-michel_cossery_photo

New managing director for Lilly UK

December 12, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly

Lilly UK has appointed Dr Jean-Michel Cosséry as the new managing director and VP of the UK Affiliate and the …

Appointment
janssen image

Alzheimer’s drug lowers mortality

December 7, 2012
Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly

A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …

News
lilly image

New plant positions Lilly for changing insulin market

November 6, 2012
Manufacturing and Production Boehringer, insulin, lilly

Eli Lilly has unveiled plans for a $140 million expansion of its insulin plant in Indianapolis as it starts to …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026